10FoldMed™ is a pioneering brand based in Israel, dedicated to combatting obesity and metabolic diseases through their cutting-edge non-invasive technology. Their innovative approach involves reversing insulin resistance by destroying visceral fat cells using their patent-pending 10Fold™ technology. This breakthrough in focused ultrasound allows for precise and controlled treatment, coupled with machine learning capabilities, marking a significant advancement in the field.

While still in the development stage, 10FoldMed™ is self-funded with support from the Israeli Innovation Authority (IIA). As an early stage startup, they are committed to revolutionizing the treatment of obesity and related conditions, with a clear vision to make a positive impact on the lives of patients. For more information about their groundbreaking work, interested individuals can reach out to 10FoldMed™ via email at admin@10foldmed.

com. Stay tuned for updates from 10FoldMed™ as they continue to innovate and save lives with their non-invasive solutions